Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Investigative Radiology|October 1, 1992
Sonographic changes during hepatic interstitial laser photocoagulation. An investigation of three optical fiber tipsD E Malone, D R Wyman, D J Moote, et al.
Neuroscience Letters|August 17, 2002
Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigraZ-H Feng, T-G Wang, D-D Li, et al.
Lasers in Surgery and Medicine|January 1, 1992
Magnetic resonance imaging of interstitial laser photocoagulation in brainR A Tracz, D R Wyman, P B Little, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharideB Liu, J W Jiang, B C Wilson, et al.
Gastrointestinal Endoscopy|April 27, 2001
Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technologyJ Haringsma, G N Tytgat, H Yano, et al.
Molecular Imaging|April 2, 2005
Combined in vivo bioluminescence and fluorescence imaging for cancer gene therapyJ D Mocanu, E H Moriyama, M C Chia, et al.
Physics in Medicine and Biology|October 6, 2011
Analytic expression of fluorescence ratio detection correlates with depth in multi-spectral sub-surface imagingF Leblond, Z Ovanesyan, S C Davis, et al.
Lasers in Surgery and Medicine|January 1, 1993
Comparison of magnetic resonance images and the histopathological findings of lesions induced by interstitial laser photocoagulation in the brainR A Tracz, D R Wyman, P B Little, et al.
The Journal of Urology|September 18, 2007
Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment responseJ Trachtenberg, A Bogaards, R A Weersink, et al.
British Journal of Pharmacology|July 6, 2011
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damageS H Chen, H M Wu, B Ossola, et al.
Pageof 16